Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

Overview
Date Founded

2000

Headquarters

1305 O'Brien Drive,Menlo Park, CA 94025

Type of Company

Public

Employees (Worldwide)

404

Industries

Industrial Machinery & Manufacturing
Medical Support Services
Biotechnology

Company Description

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Contact Data
Trying to get in touch with decision makers at Pacific Biosciences of California, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

President, Chief Executive Officer & Director

Executive Vice President & Chief Financial Officer

Chief Scientific Officer

Senior Vice President Research & Development

Head-Investor Relations

Senior Director

Senior Director

Senior Director

Board of Directors

Former General Accounting Manager at Sugen LLC

Executive Vice President & Chief Financial Officer at Intuitive Surgical, Inc.

Virginia & D.K. Ludwig Professor of Cancer Research & Director, Beckman Center at Stanford University

Co-Founder at Celera Corp.

Chief Scientific Officer at Calico LLC

Vice President for Business Affairs & Chief Financial Officer at Stanford University

Former Non-Executive Chairman & Chief Executive Officer at RainDance Technologies, Inc.

President, Director at Gilead Pharmasset LLC

Managing Partner at Mohr Davidow Ventures

Paths to Pacific Biosciences of California, Inc.
Potential Connections via
Relationship Science
You
Pacific Biosciences of California, Inc.
Owners & Shareholders
Details Hidden

CNH is a discretionary asset management firm specializing in arbitrage investments. The firm's core investment strategies include convertible arbitrage and merger arbitrage; however, they manage other arbitrage strategies including when-issued arbitrage, stub-trading arbitrage, dual-class arbitrage, and price-pressure arbitrage. CNH also manages a limited number of alternative investment strategies including, SPACs, closed-end funds, distressed securities and PIPEs. To implement their arbitrage strategies and other alternative investment strategies, the firm employs fundamental securities analysis.

Details Hidden

Magnetar Financial implements a variety of different strategies in managing private investment funds and separately managed accounts (SMAs) which designed to achieve attractive risk-adjusted rates of return. Some of the funds and SMAs employ a multi-strategy approach, utilizing a wide range of strategies across a range of geographies, while others focus on one or just a few strategies. It may hold both long and short positions in a broad range of securities, derivatives, and other assets. In executing their investment strategies, the funds and SMAs may enter into joint venture or co-investment arrangements, participate in pooled investment vehicles, invest with affiliated or unaffiliated advisors or managers, or make direct investments in operating entities. Magnetar Financial may use leverage in the investing activities and may engage in short selling. The firm's main investment strategies are divided into the following categories: relative-value, event-driven, directional, hybrid and other investment strategies.

Details Hidden

Water Island Capital specializes in event-driven investing strategies, including strategies focused on merger arbitrage, equity special situations, and credit opportunities. These strategies are available to prospective institutional and retail clients through public mutual funds, institutional separate accounts and private funds. Water Island may use derivatives, such as options, as well as short selling or purchase of related securities and those of peer companies, to isolate the outcome of the investment in a particular \"event\" from the broader directional moves of the securities markets. The Arbitrage Funds currently offer four series: The Arbitrage Fund, The Arbitrage Event-Driven Fund, The Arbitrage Tactical Equity Fund and The Arbitrage Credit Opportunities Fund.

Recent Transactions
Details Hidden

Pacific Biosciences of California, Inc. issued . USD Common Stock

Details Hidden

Pacific Biosciences of California, Inc. issued USD Common Stock

Details Hidden

Pacific Biosciences of California, Inc. issued . USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onPacific Biosciences of California, Inc. issued . USD Common Stock

Escrow Agent

Advised onPacific Biosciences of California, Inc. issued . USD Common Stock

Escrow Agent

Advised onPacific Biosciences of California, Inc. issued USD Common Stock

Legal Advisor

Advised onPacific Biosciences of California, Inc. issued USD Common Stock

Legal Advisor

Advised onPacific Biosciences of California, Inc. issued . USD Common Stock

Head of Investment Banking

Advised onPacific Biosciences of California, Inc. issued . USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Clients

Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. The genetic testing includes medical products and services, and basic research services. Medical products and services are divided into medical testing services, reagent sales, and equipment sales. Medical testing services are mainly divided into two applications: genetics and oncology. The company was founded on April 14, 1997 and is headquartered in Beijing, China.

Key Stats and Financials As of 2019
Market Capitalization
$415M
Total Enterprise Value
$797M
Earnings Per Share
$-0.55
Revenue
$90.9M
Net Profit
$-84.1M
Total Equity
$54.9M
Total Debt
$61.7M
Enterprise Value Sales
8.76x
TEVNet Income
-9.47x
Debt TEV
0.08x
EBITDAMargin
-99.68%
EBITDA
$-90.6M
Three Year Compounded Annual Growth Rate Of Revenue
0.07%
Five Year Compounded Annual Growth Rate Of Revenue
8.45%
Investors
Details Hidden

Deerfield Management Co. LP (Private Equity) invests in a broad range of industries. It provides financing for buyout transactions to private and public companies located in the U.S.

Details Hidden

BR Ventures provides incubation services and seed capital to selected start-ups within the Cornell community. Initial investments typically range from $50,000 to $200,000 and up to $10 million over the life of a company

Details Hidden

Co-Founder at Goldfinch Biopharma, Inc.

Suppliers
Cornell University Computer Software | Ithaca, New York

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

General Electric Company Shipping & Delivery | Boston, MA

General Electric Co. is a technology and financial services company. It operates through the following segments: Power, Renewable Energy, Aviation, Healthcare, and Capital. The Power segment offers technologies, solutions, and services related to energy production, which includes gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides wind turbine platforms, hardware & software, offshore wind turbines, solutions, products & services to hydropower industry, blades for onshore & offshore wind turbines, and high voltage equipment. The Aviation segment provides jet engines & turboprops for commercial airframes, maintenance, component repair, and overhaul services, as well as replacement parts, additive machines & materials, and engineering services. The Healthcare segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases & finances aircraft, aircraft engines and helicopters, and also provides financial and underwriting solutions. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Boston, MA.

Resources Connection, Inc. Management Consulting | Irvine, CA

Resources Connection We serve business from the inside. Partnering with client teams, we solve problems, implement initiatives and help drive change through all levels of businesses all over the world. Traditional consulting firms hire right out of school. We employ seasoned professionals so they can start adding value as soon as they begin an engagement. Our professionals are experienced problem solvers with 15-20 years experience in fields including finance and accounting, human capital, information management, internal audit, legal and supply chain. From 75 offices in North America, Europe and Asia Pacific, RGP serves 1,900 clients in 70 countries. We're a pioneering professional services firm, a global community with a new approach to consulting - from the inside out.

Competitors
Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Illumina, Inc. Industrial Machinery & Manufacturing - San Diego, CA

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Awards & Honors
2010
World Economic Forum - Technology Pioneers
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pacific Biosciences of California, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pacific Biosciences of California, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Pacific Biosciences of California, Inc..